MiCardia Corporation (MiCardia) is a privately held medical device company engaged in the design, development and commercialization of minimally invasive methods to treat mitral valve regurgitation, tricuspid valve regurgitation and congestive heart failure. The company has developed a technology platform to dynamically optimize mitral valve and tricuspid valve repair. MiCardia offers implantable devices for dynamic repair of heart valves and interruption of progression to heart failure. Its products include a wide range of advanced annuloplasty rings which may be adjusted dynamically after they are surgically placed. The company is headquartered at Irvine in California, the US.

Street: 
30 Hughes
City: 
Irvine
Postcode: 
92618
Federal State : 
United States
WebSite: 
ww.micardia.com
Fax: 
1-949-9514812

Company Index Score

Current Index Score Historical Index Score
  • MiCardia Corporation currently scores 50 % in the index.
  • MiCardia Corporation is currently ranked equal 15 out of a total of 35419 included in the NS Company Index. This is the top 0.042 % of all companies.
  • MiCardia Corporation is currently ranked 3 out of 8430 companies. This is in the top 0.036 % percent of Healthcare companies ranked in the index.
  • User perception of the company stands at 0 % percent. This differs 50 % percent over the score attributed to the company by other scoring factors.

Latest tweets